|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
WHO00433471X |
003 |
DE-627 |
005 |
20230605130633.0 |
007 |
cr uuu---uuuuu |
008 |
210507s2023 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)WHO00433471X
|
035 |
|
|
|a (UBBS_Klinische_Studien_WHO)RBR-7jqpnw
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
245 |
1 |
0 |
|a Effect of COVID-19 convalescent plasma produced by HEMOPE: A randomized study, with a comparative group in several centers
|b Therapeutic effectiveness of COVID-19 convalescent plasma produced by HEMOPE: a multicenter, randomized and controlled clinical trial - PLAVID-TRIAL: Covid convalescent plasma - Clinical Trial
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 29-06-2020, Last updated: 2023-06-05
|
650 |
|
4 |
|a Medical Condition: Diabetes Mellitus; Hypertension; Lung Diseases; Respiratory Insufficiency; Respiration, Artificial; Critical Care; Hospitalization;C18.452.394.750;C14.907.489;C08.381;C08.618.846;E02.041.625;E02.760.190;E02.760.400
|
650 |
|
4 |
|a Study Type: Interventional
|
650 |
|
4 |
|a Recruitment Status: Not yet recruiting
|
650 |
|
4 |
|a 610
|
773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2023) vom: 29. Mai
|
773 |
1 |
8 |
|g year:2023
|g day:29
|g month:05
|
856 |
4 |
0 |
|u http://ensaiosclinicos.gov.br/rg/RBR-7jqpnw
|z kostenfrei
|3 Volltext
|
912 |
|
|
|a GBV_CTG
|
951 |
|
|
|a AR
|
952 |
|
|
|j 2023
|b 29
|c 05
|